Literature DB >> 8503867

Cellular signalling mechanisms in B lymphocytes.

W Cushley1, M M Harnett.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8503867      PMCID: PMC1134213          DOI: 10.1042/bj2920313

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  228 in total

1.  Multiple hematopoietic growth factors signal through tyrosine phosphorylation.

Authors:  R J Isfort; J N Ihle
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

2.  The role of I-A/E molecules in B lymphocyte activation. I. Inhibition of lipopolysaccharide-induced responses by monoclonal antibodies.

Authors:  S Forsgren; G Pobor; A Coutinho; M Pierres
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

Review 3.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

4.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

5.  Phosphorylation of class I but not class II MHC molecules by membrane-localized protein kinase C.

Authors:  T Burke; K Pollok; W Cushley; E C Snow
Journal:  Mol Immunol       Date:  1989-12       Impact factor: 4.407

6.  Mechanisms of formation of IgE-binding factors (soluble CD23)--I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights.

Authors:  M Letellier; M Sarfati; G Delespesse
Journal:  Mol Immunol       Date:  1989-12       Impact factor: 4.407

7.  Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis.

Authors:  B Margolis; A Zilberstein; C Franks; S Felder; S Kremer; A Ullrich; S G Rhee; K Skorecki; J Schlessinger
Journal:  Science       Date:  1990-05-04       Impact factor: 47.728

8.  Activation of antigen-enriched B cells. II. Role of linked recognition in B cell proliferation to thymus-dependent antigens.

Authors:  E C Snow; R J Noelle; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

9.  Interleukin-induced increase in Ia expression by normal mouse B cells.

Authors:  N W Roehm; H J Leibson; A Zlotnik; J Kappler; P Marrack; J C Cambier
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

10.  B cell activation. I. Anti-immunoglobulin-induced receptor cross-linking results in a decrease in the plasma membrane potential of murine B lymphocytes.

Authors:  J G Monroe; J C Cambier
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  5 in total

1.  The role of the Fgr tyrosine kinase in the control of the adhesive properties of U937 monoblastoid cells and their derivatives.

Authors:  L Faulkner; M Patel; P M Brickell; D R Katz
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

Review 2.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

3.  Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.

Authors:  W Siffert; D Rosskopf; A Moritz; T Wieland; S Kaldenberg-Stasch; N Kettler; K Hartung; S Beckmann; K H Jakobs
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

4.  Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes.

Authors:  M A Valentine; A J Czernik; N Rachie; H Hidaka; C L Fisher; J C Cambier; K Bomsztyk
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

5.  The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein.

Authors:  M Terashima; K M Kim; T Adachi; P J Nielsen; M Reth; G Köhler; M C Lamers
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.